Work

Serum IL-6 and CRP as prognostic factors in melanoma patients receiving single agent and combination checkpoint inhibition.

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.100

Authors: Jeffrey S. Weber, Hao Tang, Lauren Hippeli, Max Qian, Megan Wind-Rotolo, James M.G. Larkin, Jedd D. Wolchok, Mario Sznol, Caroline Robert, David Michael Woods, Andressa Sodre Laino, F. Stephen Hodi

Institutions: NYU Langone Health, NYU Langone’s Laura and Isaac Perlmutter Cancer Center, Bristol-Myers Squibb (United States), Celgene (United States), Royal Marsden NHS Foundation Trust, Memorial Sloan Kettering Cancer Center, Yale New Haven Hospital, Yale Cancer Center, Smilow Cancer Hospital, Institut Gustave Roussy, Dana-Farber Cancer Institute

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2947713025

Cites:

Cited by: 47

Related to: 10